Rapid AST Speeds Care, Not Outcomes - Takeaways - MDSpire
From the Journals
Conference News

Rapid AST Speeds Care, Not Outcomes

Faster antibiotic optimization may still support use of rapid testing, particularly when paired with stewardship.

  • By

  • Kathryn Wighton

  • May 6, 2026

  • 5 min

Share

  • 1

    Rapid AST did not show superiority in mortality outcomes.

  • 2

    Faster antibiotic modification was observed with rapid AST.

  • 3

    Study involved 899 patients across multiple countries.

  • 4

    Lower time to effective therapy was noted in resistant infections.

  • 5

    Factors influencing outcomes included local practices and antibiotic availability.

  • 6

    Editorial commentary suggests practical benefits of rapid testing in resistant infections.

  • 7

    Study limitations include open label design and variable workflow across sites.

Original Source(s)

Rapid AST Speeds Care, Not Outcomes

  • by Kathryn Wighton

  • May 6, 2026

Related Content

Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment

  • May 7, 2026

  • 2 min
Measuring Aerosol Chemistry in Minutes 

Nanoelectromechanical FTIR analyzes nanogram-scale aerosol samples, reducing collection times from week-long campaigns to minutes

  • May 7, 2026

  • 2 min
Dalbavancin Exposure Linked to Higher Success in Bacteremia

Higher day 22 concentrations were associated with improved outcomes, though findings remain exploratory